Stress responsiveness of the hypothalamic-pituitary-adrenal axis: Agerelated features of the vasopressinergic regulation

Frontiers in Endocrinology

Volumn 4, Issue MAR, 2013, Pages

  Goncharova, Nadezhda D ^a,b  

^a Research Institute of Medical Primatology   (Russian Federation)

^b SOCHI STATE UNIVERSITY   (Russian Federation)

Author keywords

Aging; hypothalamic pituitary adrenal axis; Stress; V1b receptors; Vasopressin

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; G PROTEIN COUPLED RECEPTOR; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; VASOPRESSIN V1B RECEPTOR;

ACUTE STRESS; ADRENALECTOMY; AGING; AMYGDALOID NUCLEUS; CELLULAR STRESS RESPONSE; CIRCADIAN RHYTHM; FEEDBACK SYSTEM; FETUS DEVELOPMENT; FORCED SWIM TEST; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HORMONAL REGULATION; HUMAN; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LACTATION; NEWBORN PERIOD; NONHUMAN; REVIEW; SENSORY NERVE; STRIA TERMINALIS; SUPRACHIASMATIC NUCLEUS; SYNAPTIC TRANSMISSION; THIRD TRIMESTER PREGNANCY;

EID: 84884195946     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2013.00026     Document Type: Review

References (217)

1. Abou-Samra, A. B., Catt, K. J., and Aguilera, G. (1986). Involvement of protein kinase C in the regulation of adrenocorticotropin release from rat anterior pituitary cells. Endocrinology 118, 212-217.
2. Aguilera, G. (1994). Regulation of pituitary ACTH secretion during chronic stress. Front. Neuroendocrinol. 15, 321-350.
3. Aguilera, G. (1998). Corticotropin releasing hormone, receptor regulation and the stress response. Trends Endocrinol. Metab. 9, 329-336.
4. Aguilera, G. (2011). HPA axis responsiveness to stress: implications for healthy aging. Exp. Gerontol. 46, 90-95.
5. Aguilera, G., Pham, Q., and Rabadan-Diehl, C. (1994). Regulation of pituitary vasopressin receptors during chronic stress: relationship with corticotroph responsiveness. J. Neuroendocrinol. 6, 299-304.
6. Aguilera, G., and Rabadan-Diehl, C. (2000). Vasopressinergic regulation of the hypothalamic-pituitary-adrenal axis: implications for stress adaptation. Regul. Pept. 96, 23-29.
7. Altemus, M., Deuster, P. A., Galliven, E., Carter, C. S., and Gold, P. W. (1995). Suppression of hypothalamic-pituitary-adrenal axis responses to stress in lacting women. J. Clin. Endocrionol. Metab. 80, 2954-2959.
8. Antoni, F., Fink, G., and Sheward, W. (1990). Corticotrophin-releasing peptides in rat hypophysial portal blood after paraventricular lesions: a marked reduction in the concentration of 41-residue corticotropin-releasing factor, but no change in vasopressin. J. Endocrinol. 125, 175-183.
9. Antoni, F. A. (1993). Vasopressinergic control of pituitary-adrenal secretion comes of age. Front. Neuroendocrinol. 14, 76-122.
10. Arima, H., House, S. B., Gainer, H., and Aguilera, G. (2002). Neuronal activity is required for the circadian rhythm of vasopressin gene transcription in the suprachiasmatic nucleus in vitro. Endocrinology 143, 4165-4171.
11. Arvat, E., Giordano, R., Grottoli, S., and Ghigo, E. (2002). Benzodiazepines and anterior pituitary function. J. Endocrinol. Invest. 25, 735-747.
12. Autelitano, D. J., Lundblud, J. R., Blum, M., and Roberts, J. L. (1989). Hormonal regulation of POMC gene expression. Annu. Rev. Physiol. 51, 715-726.
13. Bale, T. L., and Vale, W. W. (2004). CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 44, 525-557.
14. Barberis, C., and Tribollet, E. (1996). Vasopressin and oxytocin receptors in the central nervous system. Crit. Rev. Neurobiol. 10, 119-154.
15. Bartanusz, V., Aubry, J. M., Jezova, D., Baffi, J., and Kiss, J. Z. (1993). Up-regulation of vasopressin mRNA in paraventricular hypophysiotropic neurons after acute immobilization stress. Neuroendocrinology 58, 625-629.
16. Baulieu, E. E. (1998). Neurosteroids: a novel function of the brain. Psychoneuroendocrinology 29, 963-987.
17. Bazhanova, E. D., Chernigovskaya, E. V., and Danilova, O. A. (2000). Different pathways of neurohormonal hypothalamic control of the adrenal cortex function in young and old rats. Mech. Ageing Dev. 118, 91-102.
18. Bilezijian, L. M., Blount, A. V., and Vale, W. W. (1987). The cellular actions of vasopressin on corticotrophs of the anterior pituitary: resistance to glucocorticoid action. Mol. Endocrinol. 1, 451-458.
19. Birnbaumer, M. (2000). Vasopressin receptors. Trends Endocrinol. Metab. 1, 406-410.
20. Blichert-Toft, M. (1978). "The adrenal glands in old age," in Geriatric Endocrinology. Aging, Vol. 5, ed. R. B. Greenblatt (New York: Raven Press), 81-104.
21. Born, J., Ditschuneit, I., Schreiber, M., Dodt, C., and Fehm, H. L. (1995). Effect of age and gender on pituitary-adrenocortical responsiveness in humans. Eur. J. Endocrinol. 132, 705-711.
22. Brooke, S. M., de Haas-Johnson, A. M., Kaplan, J. R., Manuck, S. B., and Sapolsky, R. M. (1994). Dexamethasone resistance among nonhuman primates associated with a selective decrease of glucocorticoid receptors in the hippocampus and a history of social instability. Neuroendocrinology 60, 134-140.
23. Brunton, P. J., Russell, J. A., and Douglas, A. J. (2008). Adaptive responses of the maternal hypothalamic-pituitary-adrenal axis during pregnancy and lactation. J. Neuroendocrinol. 20, 764-777.
24. Burgess, W. J., and Balment, R. J. (1992). Plasma atrial natriuretic peptide in vasopressin deficiency: the effect of acute water deprivation in rats. J. Endocrinol. 135, 431-438.
25. Caff, A. R., van Leeuwen, F. W., and Luiten, P. G. (1987). Vasopressin cells in the medial amygdala of the rat project to the lateral septum and ventral hippocampus. J. Comp. Neurol. 261, 237-252.
26. Cai, A., Scarbrough, K., Hinkle, A., and Wise, P. M. (1997). Fetal grafts containing suprachiasmatic nuclei restore the diurnal rhythm of CRH and POMC mRNA in aging rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 273, R1764-R1770.
27. Carey, L. C., Tatter, S. B., and Rose, J. C. (2007). Ontogeny and effects of hypothalamic pituitary disconnection on formation of inositol trisphosphate in fetal sheep pituitary cells. Endocrinology 148, 1440-1444.
28. Carey, L. C., Tatter, S. B., and Rose, J. C. (2009). Cortisol infusion in late-gestation hypothalamo-pituitary disconnected sheep fetus pituitary cell responsiveness to arginine vasopressin. Am. J. Physiol. Endocrinol. Metab. 296, E300-E304.
29. Cayetanot, F., Bentivoglio, M., and Aujard, E. (2005). Arginine-vasopressin and vasointestinal polypeptide rhythms in the suprachiasmatic nucleus of the mouse lemur reveal aging-related alterations of circadian pacemaker neurons in a non-human primate. Eur. J. Neurosci. 22, 902-910.
30. Ceresini, G., Morganti, S., Rebecchi, I., Freddi, M., Ceda, G. P., Banchini, A., et al. (2000). Evaluation of the circadian profiles of serum dehygroepiandrosterone (DHEA), cortisol, and cortisol/DHEA molar ratio after a single oral administration of DHEA in elderly subjects. Metab. Clin. Exp. 49, 548-551.
31. Chambers, K. S., Resko, J. A., and Phoenix, C. H. (1982). Correlation of diurnal changes in hormones with sexual behavior and age in male rhesus macaques. Neurobiol. Aging 3, 37-42.
32. Chen, J., Volpi, S., and Aguilera, G. (2008a). Anti-apoptotic actions of vasopressin in H32 neurons involve map kinase transactivation and bad phosphorylation. Exp. Neurol. 211, 529-538.
33. Chen, J., Young, S., Subburaju, S., Sheppard, J., Kiss, A., Atkinson, H., et al. (2008b). Vasopressin does not mediate hypersensitivity of the hypothalamic pituitary adrenal axis during chronic stress. Ann. N. Y. Acad. Sci. 1148, 349-359.
34. Chirkov, A. M., Chirkova, S. K., and Startsev, V. G. (1987). Emotional Stress in Monkeys. Leningrad: Nauka.
35. Chrousos, G. P. (2000). The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuroendocrine and target tissue-related causes. Int. J. Obes. Relat. Metab. Disord. 24(Suppl. 2), S50-S55.
36. Cizza, G., Calogero, A. E., Brady, L. S., Bagdy, G., Bergamini, E., Blackman, M. R., et al. (1994). Male Fischer 344/N rats show a progressive central impairment of the hypothalamic-pituitary-adrenal axis with advancing age. Endocrinology 134, 1611-1621.
37. Conley, A. J., Pattison, J. C., and Bird, I. M. (2004). Variations in adrenal androgen productions among (nonhuman) primates. Semin. Reprod. Med. 22, 311-326.
38. da Costa, A. P. C., Wood, S., Ingram, C. D., and Lightman, S. L. (1996). Region-specific reduction in stress-induced c-foc mRNA expression during pregnancy and lactation. Brain Res. 742, 177-184.
39. Dallman, M. F., Akana, S. F., Levin, N., Walker, C.-D., Bradbury, M. J., Suemaru, S., et al. (1994). Corticosteroids and the control of function in the hypothalamopituitary-adrenal (HPA) axis. Ann. N. Y. Acad. Sci. 746, 22-28.
40. DeBold, C. R., Sheldon, W. R., DeCherney, G. S., Jackson, R. V., Alexander, A. N., Vale, W., et al. (1984). Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor. J. Clin. Invest. 73, 533-538.
41. De Goeij, D., Djikstra, H., and Tilders, F. (1992). Chronic psychosocial stress enhances vasopressin but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status. Endocrinology 131, 847-853.
42. de Kloet, C. S., Vermetten, E., Geuze, E., Wiegant, V. M., and Westenberg, H. G. (2008). Elevated plasma arginine vasopressin levels in veterans with posttraumatic stress disorder. J. Psychiatr. Res. 42, 192-198.
43. de Kloet, E. R., Joels, M., and Holsboer, F. (2005). Stress and the brain: from adaptation to disease. Nat. Rev. Neurosci. 6, 463-475.
44. de Weerth, C., and Buitelaar, J. K. (2005). Physiological stress reactivity in human pregnancy: a review. Neurosci. Biobehav. Rev. 29, 295-312.
45. De Weerth, C., Wied, C. C., Jansen, L. M., and Buitelaar, J. K. (2007). Cardiovascular and cortisol responses to a psychological stressor during pregnancy. Acta Obstet. Gynecol. Scand. 29, 1-12.
46. de Winter, R. F., van Hemert, A. M., Derijk, R. H., Zwindermann, K. H., Frankhuijzen-Sierevogel, A. C., Wiegant, V. M., et al. (2003). Anxious-retarded depression: relation with plasma vasopressin and cortisol. Neuropsychopharmacology 28, 140-147.
47. Dent, G. W., Smith, M. A., and Levine, S. (1999). The ontogeny of the neuroendocrine response to endotoxin. Brain Res. Dev. Brain Res. 117, 21-29.
48. Derick, S., Pena, A., Durroux, N., Wagnon, J., Serradeil-Le Gal, C., Hibert, M., et al. (2004). Key amino acid located within the transmembrane domains 5 and 7 account for the pharmacological specificity of the human V1b vasopressin receptor. Mol. Endocrinol. 18, 2777-2789.
49. Deuster, P. A., Faraday, M. M., Chrousos, G. P., and Poth, M. A. (2005). Effects of dehydroepiandrosterone and alprazolam on hypothalamic-pituitary responses to exercise. J. Clin. Endocrinol. Metab. 90, 4777-4783.
50. Dinan, T. G., and Scott, L. V. (2005). Anatomy of melancholia: focus on hypothalamic-pituitary-adrenal axis overactivity and the role of vasopressin. J. Anat. 207, 259-264.
51. Domokos, A., Mergle, Z., Barna, I., Makara, G. B., and Zelena, D. (2008). Congenital vasopressin deficiency and acute and chronic opiate effects on hypothalamopituitary-adrenal axis activity in Brattleboro rats. J. Endocrinol. 196, 113-121.
52. Douglas, A. J., Brunton, P. J., Bosach, O. J., Russell, J. A., and Neumann, A. D. (2003). Neuroendicrine responses to stress in mice: hyporesponsiveness in pregnancy and parturition. Endocrinology 144, 5268-5276.
53. Ellis, M. J., Schmidli, R. S., Donald, R. A., Liversey, J. H., and Espiner, E. A. (1990). Plasma corticotrophin-releasing factor and vasopressin responses to hypoglycemia in normal man. Clin. Endocrinol. (Oxf.) 32, 93-100.
54. Engler, D., Pham, T., Fullerton, M. J., Ooi, G., Funder, J. W., and Clarke, I. J. (1989). Studies of the secretion of corticotrophin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia. Neuroendocrinology 49, 367-381.
55. Evans, M. J., Marshall, A. G., Kitson, N. E., Summers, K., and Donald, R. A. (1993). Factors affecting ACTH release from perfused equine anterior pituitary cells. J. Endocrinol. 137, 391-401.
56. Familari, M., Smith, A. I., Smith, R., and Funder, J. W. (1989). Arginine vasopressin is a much more potent stimulus to ACTH release from ovine anterior pituitary cells than ovine corticotrophin-releasing factor. Neuroendocrinology 50, 152-157.
57. Favrod-Coune, C., Raux-Demay, M., Proeschel, M., Bertagna, X., Girard, F., and Luton, J. P. (1993). Potentiation of the classic ovine corticotropin-releasing hormone stimulation test by the combined administration of small doses of lysine vasopressin. Clin. Endocrinol. (Oxf.) 38, 405-410.
58. Fenoglio, K. A., Brunson, K. L., Vishai-Eliner, S., Chen, Y., and Baram, T. Z. (2004). Region-specific onset of handling-induced changes in corticotropin-releasing factor and glucocorticoid receptor expression. Endocrinology 145, 2702-2706.
59. Ferrari, E., Cravello, L., Muzzoni, B., Casarotti, D., Paltro, M., Solerte, S. B., et al. (2001). Age-related changes of the hypothalamic-pituitary-adrenal axis: pathophysiological correlates. Eur. J. Endocrinol. 144, 319-329.
60. Fischer, D., Patchev, V. K., Hellbach, S., Hassan, A. H., and Almeida, O. F. (1995). Lactation as a model for naturally reversible hypercortisolism plasticity in the mechanisms governing hypothalamo-pituitary-adrenocortical activity in rats. J. Clin. Invest. 96, 1208-1215.
61. Froy, O. (2011). Circadian rhythms, aging, and life span in mammals. Physiology (Bethesda) 26, 225-235.
62. Funder, J. W. (1997). Glucocorticoid and mineralocorticoid receptors: biology and clinical relevance. Annu. Rev. Med. 48, 231-240.
63. Giordano, R., Bo, M., Pellegrino, M., Vezzari, M., Baldi, M., Picu, A., et al. (2005). Hypothalamus-pituitary-adrenal hyperactivity in human aging is partially refractory to stimulation by mineralocorticoid receptor blockade. J. Clin. Endocrinol. Metab. 90, 5656-5662.
64. Gomez, F., Chapleur, M., Fernette, B., Burlet, C., Nicolas, J. P., and Burlet, A. (1997). Arginine vasopressin (AVP) depletion in neurons of the suprachiasmatic nuclei affects the AVP content of the paraventricular neurons and stimulates adrenocorticotropic hormone release. J. Neurosci. Res. 50, 565-574.
65. Goncharova, N. D. (1997). Hormonal function of the adrenal glands in men and monkeys in hemoblastoses and during aging. Bull. Exp. Biol. Med. 124, 804-807.
66. Goncharova, N. D. (2006). Hypothalamic-pituitary-adrenal axis and antioxidant enzymes: circadian rhythms, stress, and aging. Front. Neuroendocrinol. 27, 52-53.
67. Goncharova, N. D. (2009a). "The hypothalamic-pituitary-adrenal axis in nonhuman primates: circadian rhythms of stress responsiveness and aging," in Primatology:Theories, Methods and Research, eds E. Potocki and J. Krasinski (New York: Nova Science Publishers), 29-52.
68. Goncharova, N. D. (2009b). Individual life history, behavior, and biomarkers of ageing. J. Nutr. Health Aging 13(Suppl. 1), S215.
69. Goncharova, N. D., and Lapin, B. A. (2000). Changes of hormonal function of the adrenal and baboons of different age groups. J. Med. Primatol. 29, 26-35.
70. Goncharova, N. D., and Lapin, B. A. (2002). Effects of aging on hypothalamic-pituitary-adrenal system function in non-human primates. Mech. Ageing Dev. 123, 1191-1201.
71. Goncharova, N. D., and Lapin, B. A. (2004). Age-related endocrine dysfunction in nonhuman primates. Ann. N. Y. Acad. Sci. 1019, 321-325.
72. Goncharova, N. D., Lapin, B. A., and Khavinson, V. K. (2002). Age-associated endocrine dysfunctions and approaches to their correction. Bull. Exp. Biol. Med. 134, 417-421.
73. Goncharova, N. D., Marenin, V. Y., and Bogatyrenko, T. N. (2008a). Stress, aging and reliability of antioxidant enzyme defense. Curr. Aging Sci. 1, 22-29.
74. Goncharova, N. D., Shmaliy, A. V., Marenin, V. Y., Smelkova, S. A., and Lapin, B. A. (2008b). Circadian and age-related changes in stress responsiveness of the adrenal cortex and erythrocyte antioxidant enzymes in female rhesus monkeys. J. Med. Primatol. 37, 229-238.
75. Goncharova, N. D., Marenin, V. Y., and Oganyan, T. E. (2010). Aging of the hypothalamic-pituitary-adrenal axis in nonhuman primates with depression-like and aggressive behavior. Aging 2, 854-866.
76. Goncharova, N. D., Oganyan, T. E., and Smelkova, S. A. (2006a). Effect of aging on stress reactivity of the adrenal cortex in laboratory primates. Dependence on the time of day. Bull. Exp. Biol. Med. 141, 368-371.
77. Goncharova, N. D., Shmaliy, A. V., Bogatyrenko, T. N., and Koltover, V. K. (2006b). Correlation between activity of antioxidant enzymes and circadian rhythms of corticosteroids in Macaca mulatta monkeys of different age. Exp. Gerontol. 41, 778-783.
78. Goncharova, N. D., Oganyan, T. E., and Taranov, A. G. (2000). Functions of the hypothalamo-hypophyseal-adrenal system in aging in female monkeys. Neurosci. Behav. Physiol. 30, 717-721.
79. Grazzini, E., Lodboerer, A. M., Perez-Martin, A., Joubert, D., and Guillon, G. (1996). Molecular and functional characterization of the V1b receptor in rat adrenal medulla. Endocrinology 137, 3906-3914.
80. Guazzo, E. P., Kirkpatrick, P. J., Goodyer, I. M., Shiers, H. M., and Herbert, J. (1996). Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J. Clin. Endocrinol. Metab. 81, 3951-3960.
81. Gunnar, M. R., and Donzella, B. (2002). Social regulation of the cortisol levels in early human development. Psychoneuroendocrinology 27, 199-220.
82. Gust, D. A., Wilson, M. E., Stocker, T., Conrad, S., Plotsky, P. M., and Gordon, T. P. (2000). Activity of the hypothalamic-pituitary-adrenal axis is altered by aging and exposure to social stress in female rhesus monkeys. J. Clin. Endocrinol. Metab. 85, 2556-2563.
83. Harbuz, M. S., and Lightman, S. L. (1989). Glucocorticoid inhibition of stress-induced changes in hypothalamic corticotrophin-releasing factor messenger RNA and proenkephalin A messenger RNA. Neuropeptides 14, 17-20.
84. Hassan, A., Chacko, S., and Mason, D. (2003). Desensitization of the adrenocorticotropin responses to arginine vasopressin and corticotrophin-releasing hormone in ovine anterior pituitary cells. J. Endocrinol. 178, 491-501.
85. Hatzinger, M., Wotjak, C. T., Naruo, T., Simchen, R., Kewck, M. E., Landgraf, R., et al. (2000). Endogenous vasopressin contributes to hypothalamic-pituitaryadrenocortical alterations in aged rats. J. Endocrinol. 164, 197-205.
86. Hauger, B. L., Thrivikraman, K. V., and Plotsky, P. M. (1994). Age-related alterations of hypothalamic-pituitary-adrenal axis function in male Fischer 344 rats. Endocrinology 134, 1528-1536.
87. Heaney, J. L. J., Phillips, A. C., and Carroll, D. (2012). Ageing, physical function, and the diurnal rhythms of cortisol and dehydroepiandrosterone. Psychoneuroendocrinology 37, 341-349.
88. Herman, J. P. (1995). In situ hybridization analysis of vasopressin gene transcription in the paraventricular and supraoptic nuclei of the rat: regulation by stress and glucocorticoids. J. Comp. Neurol. 363, 15-27.
89. Herman, J. P., Prewitt, C. M., and Cullinan, W. E. (1996). Neuronal circuit regulation of the hypothalamo-pituitary-adrenocortical stress axis. Crit. Rev. Neurobiol. 10, 371-394.
90. Heuser, I., Deuschle, M., Weber, A., Kniest, A., Ziegler, C., Weber, B., et al. (2000). The role of mineralocorticoid receptors in the circadian activity of the human hypothalamus-pituitary-adrenal system: effect of age. Neurobiol. Aging 21, 585-589.
91. Hofman, M. A., and Swaab, D. F. (2006). Living by the clock: the circadian pacemaker in older people. Ageing Res. Rev. 5, 33-51.
92. Honma, S., Katsuno, Y., Abe, H., and Honma, K. (1996). Aging affects development and persistence of feeding-associated circadian rhythm in rat plasma corticosterone. Am. J. Physiol. Regul. Integr. Comp. Physiol. 271, R1514-R1520.
93. Huizenga, N. A. T. M., Koper, J. W., De Lange, P., Pols, H. A. P., Stolk, R. P., Grobbee, D. E., et al. (1998). Interperson variability but interperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to low dose of dexamethasone in elderly individuals. J. Clin. Endocrinol. Metab. 83, 47-54.
94. Hylka, V., Sonntag, W., and Meites, J. (1984). Reduced ability of old male rats to release ACTH and corticosterone in response to CRF administration. Proc. Soc. Exp. Biol. Med. 175, 1-3.
95. Imaki, T., Nahan, J. L., Rivier, C., Sawchenko, P. E., and Vale, W. (1991). Differential regulation of corticotropin-releasing factor mRNA in rat brain regions by glucocorticoids and stress. J. Neurosci. 11, 585-599.
96. Ishunina, T. A., and Swaab, D. F. (1999). Vasopressin and oxytocin neurons of the human supraoptic and paraventricular nucleus; size changes in relation to age and sex. J. Clin. Endocrinol. Metab. 84, 4637-4644.
97. Jacobson, L., Muglia, L. J., Weninger, S. C., Pacak, K., and Majzoub, J. A. (2000). CRH deficiency impairs but does not block pituitary-adrenal responses to diverse stressors. Neuroendocrinology 71, 79-87.
98. Jacobson, L., and Sapolsky, R. (1991). The role of hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr. Rev. 12, 118-134.
99. Jard, S., Barberis, C., Audigier, S., and Tribollet, E. (1987). Neurohypophyseal hormone receptor systems in brain and periphery. Prog. Brain Res. 72, 173-187.
100. Kalsbeek, A., Fliers, E., Hofman, M. A., Swaab, D. F., and Buijs, R. M. (2010). Vasopressin and the output of the hypothalamic biological clock. J. Neuroendocrinol. 22, 362-372.
101. Keck, M. E., Hatzinger, M., Wotjak, C. T., Landgraf, R., Holsboer, F., and Neumann, I. D. (2000). Ageing alters intrahypothalamic release patterns of vasopressin and oxytocin in rats. Eur. J. Neurosci. 12, 1487-1494.
102. Keck, M. E., Wigger, A., Welt, T., Muller, M. B., Gesing, A., Reul, J. M. H. M., et al. (2002). Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology 26, 94-105.
103. Kemnitz, J. W., Roecker, E. B., Haffa, A. L. M., Pinheiro, J., Kurzman, I., Ramsey, J. J., et al. (2000). Serum dehydroepiandrosterone sulfate concentrations across the life span of laboratory-housed rhesus monkeys. J. Med. Primatol. 29, 330-337.
104. Khavinson, V. Kh., Goncharova, N. D., and Lapin, B. A. (2001). Synthetic tetrapeptide epitalon restores disturbed neuroendocrine regulation in senescent monkeys. Neuroendocrinol. Lett. 22, 251-254. Knepper, M. A. (1997). Molecular physiology of urinary concentrating mechanism: regulation of aquaporin water channels by vasopressin. Am. J. Physiol. 272, F3-F12.
105. Kondratova, A. A., and Kondratov, R. V. (2012). The circadian clock and pathology of the ageing brain. Nat. Rev. Neurosci. 13, 325-335.
106. Koshimizu, T., Nasa, Y., Tanoue, A., Oikawa, R., Kawahara, Y., Kiyono, Y., et al. (2006). V1a vasopression receptors maintain normal blood pressure by regulation circulating blood volume and baroreflex sensitivity. Proc. Natl. Acad. Sci. U.S.A. 103, 7807-7812.
107. Kovacs, K., Kiss, J. Z., and Makara, G. B. (1986). Glucocorticoid implants around the hypothalamic paraventricular nucleus prevent the increase of corticotrophin releasing factor and arginine vasopressin immunostaining induced by adrenalectomy. Neuroendocrinology 44, 229-234.
108. Kudielka, B. M., Hellhammer, J., Hellhammer, D. H., Wolf, O. T., Pirke, K. M., Varadi, E., et al. (1998). Sex differences in endocrine and psychological responses to psychosocial stress in healthy elderly subjects and the impact of a 2-week dehydroepiandrosterone treatment. J. Clin. Endocrinol. Metab. 83, 1756-1761.
109. Kudielka, B. M., Schmidt-Reinwald, A. K., Hellhammer, D. H., and Kirschbaum, C. (1999). Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Neuroendocrinology 70, 422-430.
110. Kudoh, A., Katagai, H., and Takazawa, T. (2001). Endocrine response to surgical stress in three patients over 100 yr. Can. J. Anaesth. 48, 340-343.
111. Labrie, F., Luu-The, V., Labrie, C., and Simard, J. (2001). DHEA and its transformation into androgens and estrogens in peripheral target tissues: intracrinology. Front. Neuroendocrinol. 22, 185-212.
112. Lightman, S. L., Windle, R. J., Julian, M. D., Harbuz, M. S., Shanks, N., Wood, S. A., et al. (2000). "Significance of pulsatility in the HPA axis," in Mechanisms and Significance of Pulsatile Hormone Secretion, ed. J. D. Veldhuis (Chichester: John Wiley), 244-260.
113. Liposits, Z., Uht, R. M., Harrison, R. W., Gibbs, F. P., Paull, W., and Bohn, M. C. (1987). Ultrastructural localization of glucocorticoid receptor (GR) in hypothalamic paraventricular neurons synthesizing corticotropin releasing factor (CRF). Histochem. Cell Biol. 87, 407-412.
114. Lo, M. L., Kau, M. M., and Wang, P. S. (2006). Effect of aging on corticosterone secretion in diestrous rats. J. Cell. Biochem. 97, 351-358.
115. Lolait, S. J., Markwick, A. J., McNally, M., Abraham, J., Smith, A. I., and Funder, J. W. (1986). Anterior pituitary cells from Brattleboro (di/di), Long-Evans and Sprague-Dawley rats contain immunoreactive arginine vasopressin. Neuroendocrinology 43, 577-583.
116. Lolait, S. L., Stewart, L. Q., Jessop, D. S., Young, W. S., and O'Carroll, A.-M. (2007). The hypothalamic-pituitary adrenal axis response to stress in mice lacking functional vasopressin V1b receptors. Endocrinology 148, 849-856.
117. Long, N. M., Nijland, M. J., Nathanielsz, P. W., and Ford, S. P. (2010). The effect of early to mid-gestational nutrient restriction on female offspring fertility and hypothalamic-pituitary-adrenal axis response to stress. J. Anim. Sci. 88, 2029-2037.
118. Lucassen, P. J., David, R., Gonatas, N. K., and Swaab, D. F. (1993). Activation of the human supraoptic and paraventricular nucleus neurons with aging and in Alzheimer's disease as judged from increasing size of the Golgi apparatus. Brain Res. 632, 105-113.
119. Lupien, S. J., Maheu, F., Tu, M., Fiocco, A., and Schramek, T. E. (2007). The effects of stress and stress hormones on human cognition: implications for the field of brain and cognition. Brain Cogn. 65, 209-237.
120. Lupien, S. J., McEwen, B. S., Gunnar, M. R., and Heim, C. (2009). Effects of stress throughout the lifespan on the brain, behavior and cognition. Nat. Rev. Neurosci. 10, 434-445.
121. Lupien, S. J., Nair, N. P. V., Briere, S., Maheu, F., Tu, M. T., Lemay, M., et al. (1999). Increased cortisol levels and impaired cognition in human aging: implication for depression and dementia in later life. Rev. Neurosci. 10, 117-139.
122. Lupien, S. J., Wilkinson, C. W., Briere, S., Menard, C., Kin, N. M. K. N. Y., and Nair, N. P. V. (2002). The modulatory effects of corticosteroids on cognition: studies in young human populations. Psychoneuroendocrinology 27, 401-416.
123. Ma, S., Shipston, M. J., Morilak, D., and Russel, J. A. (2005). Reduced hypothalamic vasopressin secretion underlies attenuated adrenocorticotropin stress responses in pregnant rats. Endocrinology 146, 1626-1637.
124. Ma, X. M., and Aguilera, G. (1999). Transcriptional responses of the vasopressin and corticotropin-releasing hormone genes to acute and repeated intraperitoneal hypertonic saline injection in rats. Brain Res. 68, 129-140.
125. Makara, G. B., Mergl, Z., and Zelena, D. (2004). The role of vasopressin in hypothalamo-pituitary-adrenal axis activation during stress: an assessment of the evidence. Ann. N. Y. Acad. Sci. 1018, 151-161.
126. Makara, G. B., Varga, J., Barna, I., Pinter, O., Klausz, B., and Zelena, D. (2012). The vasopressin-deficient Brattleboro rat: lessons for the hypothalamo-pituitaryadrenal axis regulation. Cell. Mol. Neurobiol. 32, 759-766.
127. Makino, S., Schulkin, J., Smith, M. A., Pacak, K., Palkovits, M., and Gold, P. W. (1995). Regulation of corticotropin-releasing hormone receptor messenger ribonucleic acid in the rat brain and pituitary by glucocorticoids and stress. Endocrinology 136, 4517-4525.
128. Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., and Mellon, S. H. (2009). Neurobiological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front. Neuroendocrinol. 30, 65-91.
129. McEwen, B. S. (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87, 873-904.
130. McFarlane, A. R., Coghlan, J., Tresham, J., and Wintour, E. M. (1995). Corticotropin-releasing factor alone, but not arginine vasopressin alone, stimulates the release of adrenocorticotropin in the conscious intact sheep. Endocrinology 136, 1821-1827.
131. Meijer, J. C., Topic, D., Steenbergen, P. J., Jochan, G., Huston, J. P., and Oitzl, M. S. (2005). Correlations between hypothalamic-pituitary-adrenal axis parameters depend on age and learning capacity. Endocrinology 146, 1372-1381.
132. Mellon, S. H., and Vaudry, H. (2001). Biosynthesis of neurosteroids and regulation of their synthesis. Int. Rev. Neurobiol. 46, 33-78.
133. Moore, R. N., Shiller, H., and Bowden, D. M. (1979). "Adrenal structure and function," in Aging in Nonhuman Primates, ed. D. M. Bowden (New York: Van Nostrand Reinhold Company), 229-247.
134. Mouri, T., Itoi, K., Takahashi, K., Suda, T., Murakami, O., Yoshinaga, K., et al. (1993). Co-localization of corticotropin-releasing factor and vasopressin in the paraventricular nucleus of human hypothalamus. Neuroendocrinology 57, 34-39.
135. Muller, M. B., Landgraf, R., Preil, J., Sillaber, I., Kresse, A. E., Keck, M. E., et al. (2000). Selective activation of the hypothalamic vasopressinergic system in mice deficient for the corticotropin-releasing hormone receptor 1 is dependent on glucocorticoids. Endocrinology 141, 4262-4269.
136. Neumann, I. D., Johnstone, H. A., Hatzinger, M., Liebsch, G., Shipston, M., Russell, J. A., et al. (1998). Attenuated neuroendocrine responses to emotional and physical stressors in pregnant rats involve adenohypophysial changes. J. Physiol. (Lond.) 508, 289-300.
137. Ohashi, M., Fujio, N., Kato, K., Nawata, H., and Ibayashi, H. (1986). Aging is without effect on the pituitary-adrenal axis in men. Gerontology 32, 335-339.
138. Ono, N., Bedran de Castro, J., Khorram, O., and McCann, S. M. (1985). Role of arginine vasopressin in control of ACTH and LH release during stress. Life Sci. 36, 1779-1786.
139. Orentreich, N., Brind, J. L., Vogelman, J. H., Andres, R., and Baldwin, H. (1992). Long-term longitudinal measurements of plasma dehydroepiandrosterone sulfate in normal men. J. Clin. Endocrinol. Metab. 75, 1002-1004.
140. Otte, C., Hart, S., Neylan, T. C., Marmar, C. R., Yaffe, K., and Mohr, D. C. (2005). A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 30, 80-91.
141. Pedersen, W. A., Wan, R., and Mattson, M. P. (2001). Impact of aging on stress-responsive neuroendocrine systems. Mech. Ageing Dev. 122, 963-983.
142. Perez-Neri, I., Montes, S., Ojeda-Lopez, C., Ramirez-Bermudez, J., and Rios, C. (2008). Modulation of neurotransmitter systems by dehydroepiandrosterone and dehydroepiandrosterone sulfate: mechanism of action and relevance to psychiatric disorders. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1118-1130.
143. Perraudin, V., Delarue, C., de Keyzer, Y., Bertagna, X., Kuhn, J. M., Contesse, V., et al. (1995). Vasopressin-responsive adrenocortical tumor in a mild Cushing's syndrome: in vivo and in vitro studies. J. Clin. Endocrinol. Metab. 80, 2661-2667.
144. Perraudin, V., Delarue, C., Lefebvre, H., Contesse, V., Kuhn, J. M., and Vaudry, H. (1993). Vasopressin stimulates cortisol secretion from human adrenocortical tissue through activation of V1 receptors. J. Clin. Endocrinol. Metab. 76, 1522-1528.
145. Pivina, C. G., Akulova, V. K., and Ordyan, N. E. (2007). Changed activity of the hypothalamic-pituitary-adrenocortical system in prenatally stressed female rat during aging. Bull. Exp. Biol. Med. 143, 740-743.
146. Plotsky, P. (1991). Pathways to the secretion of adrenocortictropin: a view from the portal. J. Neuroendocrinol. 3, 1-9.
147. Plotsky, P. M., Bruhn, T. O., and Vale, W. (1985). Hypophysiotropic regulation of adrenocorticotropin secretion in response to insulin-induced hypoglycemia. Endocrinology 117, 323-329.
148. Prelevic, G. M., and Jacobs, H. S. (1997). Menopause and post-menopause. Baillieres Clin. Endocrinol. Metab. 11, 311-340.
149. Raadsheer, F. C., Sluiter, A. A., Ravid, R., Tilders, F. J. H., and Swaab, D. F. (1993). Localization of corticotrophin-releasing hormone (CRH) neurons in the paraventricular nucleus of the human hypothalamus; age-dependent colocalization with vasopressin. Brain Res. 615, 50-62.
150. Rabadan-Diehl, C., and Aguilera, G. (1998). Glucocorticoids increase vasopressin V1b receptor coupling to phospholipase C. Endocrinology 139, 3220-3226.
151. Rabadan-Diehl, C., Lolait, S., and Aguilera, G. (1995). Regulation of the pituitary V1b receptor mRNA during stress in the rat. J. Neuroendocrinol. 7, 903-910.
152. Raskind, M. A., Peskind, E. R., Pascualy, M., Edland, S. D., Dobie, D. J., Murray, S., et al. (1995). The effects of normal aging on cortisol and adrenocorticotropin responses to hypertonic saline infusion. Psychoneuroendocrinology 20, 637-644.
153. Ratka, A., Sutanto, W., Bloemers, M., and de Kloet, E. R. (1989). On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation. Neuroendocrinology 50, 117-123.
154. Renard, G. M., Rivarola, M. A., and Suarez, M. M. (2010). Gender-dependent effects of early maternal separation and variable chronic stress on vasopressinergic activity and glucocorticoid receptor expression in adult rats. Dev. Neurosci. 32, 71-80.
155. Reppert, S. M., and Weaver, D. R. (2002). Coordination of circadian timing in mammals. Nature 418, 935-941.
156. Revskoy, S., and Redei, E. (2000). Decreased in vitro sensitivity to dexamethasone in corticotropes from middle-age rats. Exp. Gerontol. 35, 237-242.
157. Rhodes, M. E., and Rubin, R. (1999). Functional sex differences ("sexual diergism") of central nervous system cholinergic systems, vasopressin, and hypothalamicpituitary-adrenal activity in mammals: a selective review. Brain Res. Brain Res. Rev. 30, 135-152.
158. Rivier, C., and Vale, W. (1983). Interaction of corticotrophin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113, 939-942.
159. Roozendaal, V., Van Gool, W. A., Swaab, D. F., Hoogendijk, J. E., and Mirmiran, M. (1987). Changes in vasopressin cells of the rat suprachiasmatic nucleus with aging. Brain Res. 409, 259-264.
160. Roper, J. A., O'Carroll, A.-M., Young, W. S., and Lolait, S. J. (2011). The vasopressin Avpr1b receptor: molecular and pharmacological studies. Stress 14, 98-115.
161. Rossi, N. F., and Chen, H. (2002). Modulation of ET (B) receptor-induced arginine-vasopressin secretion by N-methyl-D-aspartate (NMDA) and ??-aminobutyric acid (GABA)-dependent mechanisms in hypothalamo-neurohypophysial explants. Clin. Sci. 103(Suppl. 48), 162S-166S.
162. Rubin, R. T., and Rhodes, M. E. (2002). Sexual diergism of hypothalamo-pituitary-adrenal cortical responses to low-dose physostigmine in elderly vs. young women and men. Neuropsychopharmacology 26, 672-681.
163. Russell, G. M., Henley, D. E., Leendertz, J., Douthwaite, J. A., Wood, S. A., Stevens, A., et al. (2010). Rapid glucocorticoid receptor-mediated inhibition of hypothalamic-pituitary-adrenal ultradian activity in healthy males. J. Neurosci. 30, 6106-6115.
164. Salata, R. A., Jarrett, D. B., Verbalis, J. G., and Robinson, A. G. (1988). Vasopressin stimulation of adrenocorticotropin hormone (ACTH) in humans. In vivo bioassay of corticotropin-releasing factor (CRF) which provides evidence for CRF mediation of the diurnal rhythm of ACTH. J. Clin. Invest. 81, 766-774.
165. Sapolsky, R., and Altman, J. (1991). Incidences of hypercortisolism and dexamethasone resistance increase with age among wild baboons. Biol. Psychiatry 30, 1008 -1013.
166. Sapolsky, R. M. (1999). Glucocorticoids, stress, and their adverse neurological effects: relevance to aging. Exp. Gerontol. 34, 721-732.
167. Sapolsky, R. M., Krey, L. C., and McEwen, B. S. (1986). The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis. Endocr. Rev. 7, 284-301.
168. Sawchenko, P. E. (1987). Evidence for a local site of action for glucocorticoids in inhibiting CRF and vasopressin expression in the paraventricular nucleus. Brain Res. 403, 213-224.
169. Sawchenko, P. E., Arias, C. A., and Mortrud, M. T. (1993). Local tetrodotoxin blocks chronic stress effects on corticotrophin-releasing factor and vasopressin messenger ribonucleic acids in hypophysiotropic neurons. J. Neuroendocrinol. 5, 341-348.
170. Scaccianoce, S., DeSciullo, A., and Angelucci, L. (1990). Age-related changes in hypothalamo-pituitary-adrenocortical axis activity in the rat. Neuroendocrinology 52, 150-155.
171. Schmidt, M. V., Sterlemann, V., Wagner, K., Niederleitner, B., Ganea, K., Liebl, C., et al. (2009). Postnatal glucocorticoid excess due to pituitary glucocorticoid receptor deficiency: differential short-and long-term consequences. Endocrinology 150, 2709-2716.
172. Seeman, T. E., and Robbins, R. J. (1994). Aging and hypothalamic-pituitary-adrenal response to challenge in humans. Endocr. Rev. 15, 233-260.
173. Serradeil-Le Gal, C., Derick, S., Brossard, G., Manning, M., Simiand, J., Gaillard, R., et al. (2003). Functional and pharmacological characterization of the first specific agonist and antagonist for the V1b receptor in mammals. Stress 6, 199-206.
174. Serradeil-Le Gal, C., Wagnon, J., Tonnerre, B., Roux, R., Garcia, G., Griebel, G., et al. (2005). An overview of SSR149415, a selective nonpeptide vasopressin V1b receptor antagonist for the treatment of stress-related disorders. CNS Drug Rev. 2005, 53-68.
175. Shanks, N., Windle, R. J., Perks, P., Wood, S., Ingram, C. D., and Lightman, S. L. (1999). The hypothalamic-pituitary-adrenal axis response to endotoxin is attenuated during lactation. J. Neuroendocrinol. 11, 857-865.
176. Sherman, B., Wysham, C., and Pfohl, B. (1985). Age-related changes in the circadian rhythm of plasma cortisol in man. J. Clin. Endocrinol. Metab. 61, 439-443.
177. Solas, M., Aisa, B., Mugueta, M. C., Del Rio, J., Tordera, R. M., and Ramirez, M. J. (2010). Interactions between age, stress and insulin on cognition: implications for Alzheimer's disease. Neuropsychopharmacology 35, 1-10.
178. Spiga, F., Harrison, L., Wood, S., Knight, D. M., MacSweeney, C. P., Thomson, F., et al. (2009). Blockade of the V1b receptor reduces ACTH, but not corticosterone secretion induced by stress without affecting basal hypothalamic-pituitary-adrenal axis activity. J. Endocrinol. 200, 273-283.
179. Stewart, L. Q., Roper, J. A., Young, W. S., O'Carroll, A.-M., and Lolait, S. J. (2008). Pituitary-adrenal response to acute and repeated mild restraint, forced swim and change in environment stress in arginine vasopressin receptor 1b knockout mice. J. Neuroendocrinol. 20, 597-605.
180. Swaab, D. F., Bao, A. M., and Lucassen, P. L. (2005). The stress system in the human brain in depression and neurodegeneration. Ageing Res. Rev. 4, 141-194.
181. Swaab, D. F., Fliers, E., and Partiman, T. S. (1985). The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res. 342, 37-44.
182. Tang, G., and Phillips, R. (1978). Some age-related changes in pituitary-adrenal function in the male laboratory rat. J. Gerontol. 33, 377-382.
183. Tanoue, A., Ito, S., Honda, K., Oshikawa, S., Kitagawa, Y., Koshimuzu, T., et al. (2004). The vasopressin V1b receptor critically regulates hypothalamic-pituitaryadrenal axis activity under both stress and resting conditions. J. Clin. Invest. 113, 302-309.
184. Terwell, D., Markerink, M., and Jolles, J. (1992). Age-related changes in concentrations of vasopressin in the central nervous system and plasma of the male Wistar rat. Mech. Ageing Dev. 65, 127-136.
185. Thibonnier, M., Coles, P., Thibonnier, A., and Shoham, M. (2002). Molecular pharmacology and modeling of vasopressin receptors. Prog. Brain Res. 139, 179-196.
186. Tilders, F. J., Berkenbosch, F., Vermes, I., Linton, E. A., and Smelik, P. G. (1985). Role of epinephrine and vasopressin in the control of the pituitary-adrenal response to stress. Fed. Proc. 44, 155-160.
187. Tizabi, Y., and Aguilera, G. (1992). Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone and vasopressin. Neuroendocrinology 56, 611-618.
188. Tizabi, Y., Aguilera, G., and Gilad, G. M. (1992). Age-related reduction in pituitary corticotropin-releasing hormone receptors in two rat strains. Neurobiol. Aging 13, 227-230.
189. Traustadottir, T., Bosch, P. R., and Matt, K. S. (2003). Gender differences in cardiovascular and hypothalamic-pituitary-adrenal axis responses to psychological stress in healthy older adult men and women. Stress 6, 133-140.
190. Traustadóttir, T., Bosch, P. R., and Matt, K. S. (2005). The HPA axis response to stress in women: effects of aging and fitness. Psychoneuroendocrinology 30, 392-402.
191. Tuckermann, J. P., Kleiman, A., McPherson, K. G., and Reichardt, H. M. (2005). Molecular mechanisms of glucocorticoids in the control of inflammation and lymphocyte apoptosis. Crit. Rev. Clin. Lab. Sci. 42, 71-104.
192. Turnbull, A. V., Lee, S., and Rivier, C. (1998). Mechanisms of hypothalamic-pituitary-adrenal axis stimulation by immune signals in the adult rat. Ann. N. Y. Acad. Sci. 840, 434-443.
193. Vale, W., Rivier, C., Brown, M. R., Spiess, J., Koob, G., Swanson, L., et al. (1983). Chemical and biological characterization of corticotropin releasing factor. Recent Prog. Horm. Res. 39, 245-270.
194. Van Cauter, E., Polonsky, K. S., and Scheen, A. J. (1997). Roles of circadian rhythmicity and sleep in human glucose regulation. Endocr. Rev. 18, 716-738.
195. Vantyghem, M. C., Balavoine, A. S., Wemeau, J. L., and Douillard, C. (2011). Hyponatremia and antidiuresis syndrome. Ann. Endocrinol. (Paris) 72, 500-512.
196. Varga, J., Domokos, A., Barna, I., Jankord, R., Bagdy, G., and Zelena, D. (2011). Lack of vasopressin does not prevent the behavioral and endocrine changes induced by chronic unpredictable stress. Brain Res. Bull. 84, 45-52.
197. Vegiopoulos, A., and Herzig, S. (2007). Glucocorticoids, metabolism and metabolic diseases. Mol. Cell. Endocrinol. 275, 43-61.
198. Vezzosi, D., Cartier, D., Regnier, C., Otal, P., Bennet, F., Parmentier, F., et al. (2007). Familian adrenocorticotropin-independent macronodular adrenal hyperplasia with aberrant serotonin and vasopressin adrenal receptors. Eur. J. Endocrinol. 156, 21-31.
199. Volpi, S., Rabadan-Diehl, C., and Aguilera, G. (2004). Vasopressinergic regulation of the hypothalamic pituitary adrenal axis and stress adaptation. Stress 7, 75-83.
200. Walker, C. D., Tilders, F. J., and Burlet, A. (2001). Increased colocalization of corticotropin-releasing factor and arginine vasopressin in paraventricular neurons of the hypothalamus in lacting rats: evidence from immunotargeted lesions and immunohistochemistry. J. Neuroendocrinol. 13, 74-85.
201. Walker, J. J., Terry, J. R., and Lightman, S. L. (2010). Origin of ultradian pulsatility in the hypothalamic-pituitary-adrenal axis. Proc. Biol. Sci. 277, 1627-1633.
202. Waltman, C., Blackman, M. R., Chrousos, G. P., Riemann, C., and Harman, S. M. (1991). Spontaneous and glucocorticoid-inhibited adrenocorticotropic hormone and cortisol secretion are similar in healthy young and old men. J. Clin. Endocrinol. Metab. 73, 495-502.
203. Wellhoener, P., Born, J., Fehm, H. L., and Dodt, C. (2004). Elevated resting and exercise-induced cortisol levels after mineralcorticoid receptor blockade with canrenoate in healthy humans. J. Clin. Endocrinol. Metab. 89, 5048-5052.
204. Wersinger, S. R., Ginns, E. I., O'Carrol, A. M., Lolait, S. J., and Young, W. S. III. (2002). Vasopressin V1b receptor knockout reduces aggressive behavior in male mice. Mol. Psychiatry 7, 975-984.
205. Whitnall, M. (1987). Vasopressin co-exists in half of the corticotropin-releasing factor neurones in the external zone of the median eminence in normal rats. Neuroendocrinology 45, 420-424.
206. Whitnall, M. (1989). Stress selectively activates the vasopressin-containing subset of corticotrophin-releasing hormone neurons. Neuroendocrinology 50, 702-707.
207. Yen, S. S. C., and Laughlin, G. A. (1998). Aging and the adrenal cortex. Exp. Gerontol. 33, 897-910.
208. Yi, S.-J., and Baram, T. Z. (1994). Corticotropin-releasing hormone mediates the response to cold stress in the neonatal rat without compensatory enhancement of the peptide's gene expression. Endocrinology 135, 2364-2368.
209. Yoshimura, A., Masui, A., Jinde, S., Kanai, H., Kato, N., and Okawa, M. (2007). Influence of age or circadian time on bcl-2 and bax mRNA expression in the rat hippocampus after corticosterone exposure. Brain Res. Bull. 73, 254-258.
210. Young, S. F., Griffante, C., and Aguilera, G. (2007). Dimerization between vasopressin V1b and corticotrophin releasing hormone type 1 receptors. Cell. Mol. Neurobiol. 27, 439-461.
211. Zelena, D., Barna, I., Pinter, O., Klausz, B., Varga, J., and Makara, G. B. (2011). Congenital absence of vasopressin and age-related changes in ACTH and corticosterone stress responses in rats. Stress 14, 420-430.
212. Zelena, D., Domokos, A., Barna, I., Mergl, Z., Haller, J., and Makara, G. B. (2008). Control of the hypothalamo-pituitary-adrenal axis in the neonatal period: adrenocorticotropin and corticosterone stress responses dissociate in vasopressin-deficient Brattleboro rats. Endocrinology 149, 2576-2583.
213. Zelena, D., Domokos, A., Jain, S. K., Jankord, R., and Filaretova, L. (2009). The stimuli-specific role of vasopressin in the hypothalamus-pituitary-adrenal axis response to stress. J. Endocrinol. 202, 263-278.
214. Zelena, D., Filaretova, L., Mergle, Z., Barna, I., Toth, Z. E., and Makara, G. B. (2006). Hypothalamic paraventricular nucleus, but not vasopressin, participates in chronic hyperactivity of the HPA axis in diabetic rats. Am. J. Physiol. Endocrinol. Metab. 290, E243-E250.
215. Zelena, D., Foldes, A., Mergl, Z., Barna, I., Kovacs, K. J., and Makara, G. B. (2004). Effects of repeated restraint stress of hypothalamo-pituitary-adrenocortical function in vasopressin deficient Brattleboro rats. Brain Res. Bull. 63, 521-530.
216. Zhdanova, I. V., Masuda, K., Quasarano-Kourkoulis, C., Rosene, D. L., Killiany, R. J., and Wang, S. (2011). Aging of intrinsic circadian rhythms and sleep in a diurnal nonhuman primate, Macaca mulatta. J. Biol. Rhythms 26, 149-159.
217. Zorrilla, E. P., and Koob, G. F. (2010). Progress in corticotropin-releasing factor-1 antagonist development. Drug Discov. Today 15, 371-383.